Vemurafenib-induced bilateral facial palsy

Journal of Postgraduate Medicine

Volumn 60, Issue 2, 2014, Pages 187-188

  Shailesh, F N U ^a   Singh, M ^a   Tiwari, U ^a   Hutchins, L F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Bilateral facial palsy; melanoma; vemurafenib

Indexed keywords

PREDNISOLONE; VEMURAFENIB; ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; INDOLE DERIVATIVE; PREDNISONE; SULFONAMIDE;

ADULT; ALOPECIA; ARTHRALGIA; ARTICLE; CASE REPORT; FACIAL NERVE PARALYSIS; FATIGUE; FOLLOW UP; HUMAN; HYPERSENSITIVITY; KERATOACANTHOMA; LIVER TOXICITY; MALE; MELANOMA; MIDDLE AGED; OVERALL SURVIVAL; PHOTOSENSITIVITY; QT PROLONGATION; RASH; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; UVEITIS; CHEMICALLY INDUCED; GENETICS; MUTATION; NEOPLASM METASTASIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; FACIAL PARALYSIS; HUMANS; INDOLES; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; PROTO-ONCOGENE PROTEINS B-RAF; SKIN; SKIN NEOPLASMS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84901476370     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.132339     Document Type: Article

References (6)

1. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl Med 2011; 364: 2507-16.
2. Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl Med 2012; 366: 707-14.
3. Pothiawala S, Lateef F. Bilateral facial nerve palsy: A diagnostic dilemma. Case Rep Emerg Med 2012;2012: 458371.
4. Naranjo CA, Fornazzari L, Sellers EM. Clinical detection and assessment of drug induced neurotoxicity. Prog Neuropsychopharmacol 1981;5: 427-34.
5. Wisler JA, Afshari C, Fielden M, Zimmermann C, Taylor S, Carnahan J, et al. RAF inhibition causes extensive multiple tissue hyperplasia and urinary bladder neoplasia in the rat. Toxicol Pathol 2011;39: 809-22.
6. Klein O, Ribas A, Chmielowski B, Walker G, Clements A, Long GV, et al. Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma. J Clin Oncol 2013;31: E215-7.